Creso Pharma Announces Regarding Global Expansion of Anibidiol

Creso Pharma Limited announced its engagement to expand the commercialization and distribution of anibidiol®, its CBD-based complimentary animal feed product following a successful launch in Switzerland. The launch of anibidiol® in Switzerland in November 2017, with animal pharmaceutical giant Virbac … Continue reading Creso Pharma Announces Regarding Global Expansion of Anibidiol

Mayne Pharma Group Launches Amiodarone 200mg Tablets in the US

Mayne Pharma Group Limited announced the launch of amiodarone tablets, 200mg in the United States. Amiodarone is a generic alternative to Cordarone® tablets, indicated for life-threatening recurrent ventricular arrhythmia. This launch complements the existing amiodarone product range that includes 100mg … Continue reading Mayne Pharma Group Launches Amiodarone 200mg Tablets in the US

MGC Pharmaceuticals Announces Malta Govt Approval for MC Licensed Facility

MGC Pharmaceuticals Ltd provide an update that it has now been given approval by Maltese Government for full medical cannabis production and cultivation facility in Malta and to construct a 4,000m2 stateof-the-art medical cannabis production and cultivation facility. MXC as … Continue reading MGC Pharmaceuticals Announces Malta Govt Approval for MC Licensed Facility

Mayne Pharma Group Announces Generic NuvaRing Accepted for Filing by FDA

Mayne Pharma Group Limited (ASX: MYX) announced its Abbreviated New Drug Application (ANDA) for generic NuvaRing® has been accepted for filing by the US Food and Drug Administration (FDA). NuvaRing is an intra vaginal hormonal contraceptive delivery device combining etonogestrel … Continue reading Mayne Pharma Group Announces Generic NuvaRing Accepted for Filing by FDA

Mayne Pharma Group Launches Doxycycline IR Capsules in the US

Mayne Pharma Group Limited (ASX: MYX) announced the launch of doxycycline monohydrate immediate release (IR) capsules (50mg, 75mg and 100mg) in the United States. Doxycycline IR capsules are a generic alternative to Monodox®, a tetracycline-class antibacterial indicated for the treatment … Continue reading Mayne Pharma Group Launches Doxycycline IR Capsules in the US